Literature DB >> 2960507

Specific factors binding to the late E2A promoter region of adenovirus type 2 DNA: no apparent effects of 5'-CCGG-3' methylation.

A Hoeveler1, W Doerfler.   

Abstract

In the regulation of eukaryotic gene expression, the interactions of several protein factors with specific signals in the promoter sequence can play a decisive role. In addition, the methylation of specific promoter sequences causes the long-term inactivation of eukaryotic promoters. The function of the regulatory signal 5-methylcytidine is complex and can be overcome by a number of factors, e.g., by the E1 proteins of adenoviruses. We studied the inactivation of the late E2A promoter of adenovirus type 2 (Ad2) DNA by the methylation of three 5'-CCGG-3' sequences at positions -215, +5, and +23, relative to one of the cap sites of this promoter. One would like to understand the mechanisms by which 5-methylcytidine residues are capable of interfering with regulatory functions in the late E2A promoter of Ad2. We have identified six different promoter sequences by DNase I protection analyses, and have shown that these sites bind specifically to host proteins (binding sites I-VI). Binding of these factors to unmethylated or 5'-CCGG-3' methylated late E2A promoter sequences was compared by gel migration delay assay or DNase I protection (footprinting) analyses. Protein binding does not appear to be affected by late E2A promoter methylation. Even after partial purification of some of these factors by chromatography on heparin-Sepharose, differences in binding to the unmethylated and the 5'-CCGG-3' methylated promoter were not observed. Even though striking differences in host factor binding were not detectable at late E2A promoter sites, it is conceivable that the functionality of promoter-bound host proteins is altered when the three 5'-CCGG-3' sequences are methylated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960507     DOI: 10.1089/dna.1987.6.449

Source DB:  PubMed          Journal:  DNA        ISSN: 0198-0238


  9 in total

Review 1.  Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control.

Authors:  L P Villarreal
Journal:  Microbiol Rev       Date:  1991-09

2.  Gene structure and transcription in mouse cells with extensively demethylated DNA.

Authors:  L A Michalowsky; P A Jones
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

3.  In vitro DNA cytosine methylation of cis-regulatory elements modulates c-Ha-ras promoter activity in vivo.

Authors:  M J Rachal; H Yoo; F F Becker; J N Lapeyre
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

Review 4.  DNA methylation. The effect of minor bases on DNA-protein interactions.

Authors:  R L Adams
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

Review 5.  Promoter inactivation or inhibition by sequence-specific methylation and mechanisms of reactivation.

Authors:  W Doerfler; A Hoeveler; B Weisshaar; P Dobrzanski; D Knebel; K D Langner; S Achten; U Müller
Journal:  Cell Biophys       Date:  1989 Aug-Oct

6.  The topology of the promoter of RNA polymerase II- and III-transcribed genes is modified by the methylation of 5'-CG-3' dinucleotides.

Authors:  I Muiznieks; W Doerfler
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

7.  Identification of positive and negative regulatory elements governing cell-type-specific expression of the neural cell adhesion molecule gene.

Authors:  M R Hirsch; L Gaugler; H Deagostini-Bazin; L Bally-Cuif; C Goridis
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

8.  Inactivation by sequence-specific methylations of adenovirus promoters in a cell-free transcription system.

Authors:  P Dobrzanski; A Hoeveler; W Doerfler
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  DNA methylation and differentiation.

Authors:  L A Michalowsky; P A Jones
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.